Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) EPS (Basic) (2020 - 2025)

Pulse Biosciences has reported EPS (Basic) over the past 6 years, most recently at -$0.29 for Q3 2025.

  • Quarterly results put EPS (Basic) at -$0.29 for Q3 2025, down 38.1% from a year ago — trailing twelve months through Sep 2025 was -$1.14 (down 42.5% YoY), and the annual figure for FY2024 was -$0.92, down 8.24%.
  • EPS (Basic) for Q3 2025 was -$0.29 at Pulse Biosciences, down from -$0.28 in the prior quarter.
  • Over the last five years, EPS (Basic) for PLSE hit a ceiling of -$0.18 in Q1 2024 and a floor of -$0.71 in Q1 2021.
  • Median EPS (Basic) over the past 5 years was -$0.28 (2025), compared with a mean of -$0.35.
  • Biggest five-year swings in EPS (Basic): soared 61.22% in 2023 and later plummeted 52.38% in 2024.
  • Pulse Biosciences' EPS (Basic) stood at -$0.52 in 2021, then skyrocketed by 57.69% to -$0.22 in 2022, then rose by 4.55% to -$0.21 in 2023, then plummeted by 52.38% to -$0.32 in 2024, then rose by 9.38% to -$0.29 in 2025.
  • The last three reported values for EPS (Basic) were -$0.29 (Q3 2025), -$0.28 (Q2 2025), and -$0.25 (Q1 2025) per Business Quant data.